Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Iftner

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
Sexually Transmitted Diseases|August 17, 2013
Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from TanzaniaMyassa Dartell, Vibeke Rasch, Christian Munk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2011
Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish womenTarik Gheit, Iris Cornet, Gary M Clifford, et al.
Journal of Virology|August 13, 2025
Activation of the HPV16 late promoter by viral E2 and cellular BRD4 and ZC3H4 proteinsJanis Renner, Karsten Boldt, Andreas Wieland, et al.
Mbio|June 29, 2023
Mus musculus papillomavirus 1 E8^E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation <i>in vivo</i>Franziska Kuehner, Margaret Wong, Elke Straub, et al.
The EMBO Journal|August 29, 2002
Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1Thomas Iftner, Michaela Elbel, Betti Schopp, et al.
Journal of Medical Virology|March 28, 2007
Prevalence of human papillomavirus types in women screened by cytology in GermanyStefanie J Klug, Meike Hukelmann, Bettina Hollwitz, et al.
International Journal of Cancer|September 25, 2018
Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV typesFreja Laerke Sand, Christian Munk, Kirsten Frederiksen, et al.
Cancer Research|November 13, 2003
The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factorsAngelika Iftner, Stefanie J Klug, Claus Garbe, et al.
BMC Infectious Diseases|December 25, 2012
Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, GermanyKarl Ulrich Petry, Alexander Luyten, Annika Justus, et al.
BMJ Open|March 11, 2020
Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluationGeorgie Weston, Caroline Dombrowski, Michael J Harvey, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
Sexually Transmitted Diseases|August 17, 2013
Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from TanzaniaMyassa Dartell, Vibeke Rasch, Christian Munk, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 30, 2011
Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish womenTarik Gheit, Iris Cornet, Gary M Clifford, et al.
Journal of Virology|August 13, 2025
Activation of the HPV16 late promoter by viral E2 and cellular BRD4 and ZC3H4 proteinsJanis Renner, Karsten Boldt, Andreas Wieland, et al.
Mbio|June 29, 2023
Mus musculus papillomavirus 1 E8^E2 represses expression of late protein E4 in basal-like keratinocytes via NCoR/SMRT-HDAC3 co-repressor complexes to enable wart formation <i>in vivo</i>Franziska Kuehner, Margaret Wong, Elke Straub, et al.
The EMBO Journal|August 29, 2002
Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1Thomas Iftner, Michaela Elbel, Betti Schopp, et al.
Journal of Medical Virology|March 28, 2007
Prevalence of human papillomavirus types in women screened by cytology in GermanyStefanie J Klug, Meike Hukelmann, Bettina Hollwitz, et al.
International Journal of Cancer|September 25, 2018
Risk of CIN3 or worse with persistence of 13 individual oncogenic HPV typesFreja Laerke Sand, Christian Munk, Kirsten Frederiksen, et al.
Cancer Research|November 13, 2003
The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factorsAngelika Iftner, Stefanie J Klug, Claus Garbe, et al.
BMC Infectious Diseases|December 25, 2012
Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, GermanyKarl Ulrich Petry, Alexander Luyten, Annika Justus, et al.
BMJ Open|March 11, 2020
Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluationGeorgie Weston, Caroline Dombrowski, Michael J Harvey, et al.
Pageof 17